BOUT
发表于 2025-3-21 19:41:21
书目名称Endocrine Disorders in Kidney Disease影响因子(影响力)<br> http://impactfactor.cn/if/?ISSN=BK0309705<br><br> <br><br>书目名称Endocrine Disorders in Kidney Disease影响因子(影响力)学科排名<br> http://impactfactor.cn/ifr/?ISSN=BK0309705<br><br> <br><br>书目名称Endocrine Disorders in Kidney Disease网络公开度<br> http://impactfactor.cn/at/?ISSN=BK0309705<br><br> <br><br>书目名称Endocrine Disorders in Kidney Disease网络公开度学科排名<br> http://impactfactor.cn/atr/?ISSN=BK0309705<br><br> <br><br>书目名称Endocrine Disorders in Kidney Disease被引频次<br> http://impactfactor.cn/tc/?ISSN=BK0309705<br><br> <br><br>书目名称Endocrine Disorders in Kidney Disease被引频次学科排名<br> http://impactfactor.cn/tcr/?ISSN=BK0309705<br><br> <br><br>书目名称Endocrine Disorders in Kidney Disease年度引用<br> http://impactfactor.cn/ii/?ISSN=BK0309705<br><br> <br><br>书目名称Endocrine Disorders in Kidney Disease年度引用学科排名<br> http://impactfactor.cn/iir/?ISSN=BK0309705<br><br> <br><br>书目名称Endocrine Disorders in Kidney Disease读者反馈<br> http://impactfactor.cn/5y/?ISSN=BK0309705<br><br> <br><br>书目名称Endocrine Disorders in Kidney Disease读者反馈学科排名<br> http://impactfactor.cn/5yr/?ISSN=BK0309705<br><br> <br><br>
Meditative
发表于 2025-3-21 21:43:59
Introduction: A Vibrant HybridityThis chapter will focus on the pharmacologic interventions for treatment of dyslipidemia in patients with chronic kidney disease (CKD). Herein, we will discuss drugs of interest for lipid management and their current and potential future use in CKD patients.
延期
发表于 2025-3-22 03:51:18
Drugs for Treatment of Dyslipidemia Available in the USAThis chapter will focus on the pharmacologic interventions for treatment of dyslipidemia in patients with chronic kidney disease (CKD). Herein, we will discuss drugs of interest for lipid management and their current and potential future use in CKD patients.
Mucosa
发表于 2025-3-22 04:32:44
Connie M. Rhee,Kamyar Kalantar-Zadeh,Gregory A. BrCovers common endocrine disorders and their impact on chronic kidney disease.Provides diagnostic guidance and a range of treatment considerations.Invaluable resource for physicians, residents, fellows
FLASK
发表于 2025-3-22 12:33:20
http://image.papertrans.cn/e/image/309705.jpg
栏杆
发表于 2025-3-22 14:10:00
http://reply.papertrans.cn/31/3098/309705/309705_6.png
栏杆
发表于 2025-3-22 19:53:40
https://doi.org/10.1007/978-3-658-08894-1r cardiovascular and kidney disease. In this context, there has been increasing interest in the impact of insulin resistance and the compensatory hyperinsulinemia on kidney disease, independent to that of the contribution of overt diabetes to the development of kidney disease. It is unknown whether
GLIB
发表于 2025-3-22 21:49:18
http://reply.papertrans.cn/31/3098/309705/309705_8.png
整洁
发表于 2025-3-23 01:58:15
https://doi.org/10.1057/9780230625310ion. While diabetes is one of the most important causes of chronic kidney disease, the gradual decline in kidney function itself causes significant changes that alter glucose homeostasis in patients with kidney disease. In many patients with diabetic nephropathy requiring dialysis, glycemic control
adduction
发表于 2025-3-23 06:37:20
Relocation of Economic Activityabetic kidney disease (DKD) remain controversial. A variety of factors associated with kidney disease and/or the uremic state can impact the accuracy and interpretability of currently available glycemic measures. Alterations in erythrocyte survival time, hemoglobin concentrations, and other factors